BioTools Innovator seeks to boost startups developing life science tools
BioTools Innovator is calling for applications to its inaugural competition to advance innovation by accelerating the growth of startups developing life science tools. Kathryn Zavala, PhD, managing director, recently discussed the program with ScienceBoard.net. Read More
NIH recommends outpatient use of Regeneron's COVID-19 antibody cocktail
Regeneron Pharmaceuticals said the U.S. National Institutes of Health (NIH) strongly recommends its Regen-CoV as an outpatient treatment for COVID-19 patients at high risk of clinical progression. Read More
Oncolytic virus shows therapeutic promise against skin cancer
Coxsackievirus combined with immunotherapy appears safe and effective against advanced skin cancer in patients who are unable to have their tumors surgically removed, according to a study to be presented at the American Association for Cancer Research 2021 annual meeting. Read More
Deargen optimizes prediction of candidate drug structures
Artificial intelligence drug discovery and development company Deargen is touting results of its controlled molecular generator technology that overcomes limitations associated with existing models of predicting molecule properties. Read More
NIH details progress of SCGE consortium
The U.S. National Institutes of Health (NIH) Somatic Cell Genome Editing (SCGE) consortium has provided a detailed update, published in Nature on April 8, of projects to develop safer and more effective genome editing methods in somatic cells. Read More
Early data suggest ImmunityBio's COVID-19 vaccine is effective
ImmunityBio has reported initial data from a phase I trial suggesting its COVID-19 vaccine candidate stimulates the generation of T cells reactive to the spike and nucleocapsid protein antigens delivered by the vaccine. Read More
CytoImmune, City of Hope ink CAR-NK cell therapy agreements
CytoImmune Therapeutics and City of Hope plan to collaborate on a portfolio of chimeric antigen receptor (CAR)-natural killer (NK) cell therapies through global exclusive licensing agreements. Read More
Vizgen raises $37M to bring Merscope platform to market
Vizgen has closed $37 million in financing to support the commercialization and manufacturing of its Merscope platform. Read More
Synthego debuts CRISPR-based cell engineering platform
Synthego has launched Eclipse, a high-throughput, CRISPR-based cell engineering platform aimed at accelerating drug discovery and validation. Read More
Stanford gains access to Twist's 'library of libraries'
Twist Bioscience has granted Stanford University access to its antibody discovery and optimization services and its "library of libraries" for biologics discovery. Read More
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter